| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Dishevelled | 2.14e-06 | 4 | 153 | 3 | PF02377 | |
| Domain | Dishevelled_fam | 2.14e-06 | 4 | 153 | 3 | IPR008339 | |
| Domain | Dishevelled_protein_dom | 2.14e-06 | 4 | 153 | 3 | IPR003351 | |
| Domain | Ig_I-set | 3.82e-06 | 190 | 153 | 10 | IPR013098 | |
| Domain | I-set | 3.82e-06 | 190 | 153 | 10 | PF07679 | |
| Domain | IGc2 | SEMA3F MXRA5 MYLK PSG4 PTK7 HMCN1 ROBO1 KDR PALLD MUSK ALPK2 | 3.85e-06 | 235 | 153 | 11 | SM00408 |
| Domain | Ig_sub2 | SEMA3F MXRA5 MYLK PSG4 PTK7 HMCN1 ROBO1 KDR PALLD MUSK ALPK2 | 3.85e-06 | 235 | 153 | 11 | IPR003598 |
| Domain | CCP | 5.11e-06 | 54 | 153 | 6 | SM00032 | |
| Domain | SUSHI | 6.34e-06 | 56 | 153 | 6 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 7.04e-06 | 57 | 153 | 6 | IPR000436 | |
| Domain | IG | SEMA3F SEMA3C MXRA5 MYLK PSG4 ICAM1 SEMA3G PTK7 HMCN1 ROBO1 KDR PALLD MUSK ALPK2 | 9.80e-06 | 421 | 153 | 14 | SM00409 |
| Domain | Ig_sub | SEMA3F SEMA3C MXRA5 MYLK PSG4 ICAM1 SEMA3G PTK7 HMCN1 ROBO1 KDR PALLD MUSK ALPK2 | 9.80e-06 | 421 | 153 | 14 | IPR003599 |
| Domain | DIX | 1.84e-05 | 7 | 153 | 3 | PF00778 | |
| Domain | DIX | 1.84e-05 | 7 | 153 | 3 | IPR001158 | |
| Domain | DIX | 1.84e-05 | 7 | 153 | 3 | PS50841 | |
| Domain | DAX | 1.84e-05 | 7 | 153 | 3 | SM00021 | |
| Domain | Growth_fac_rcpt_ | 4.40e-05 | 156 | 153 | 8 | IPR009030 | |
| Domain | CUB | 4.93e-05 | 49 | 153 | 5 | PF00431 | |
| Domain | IG_LIKE | SEMA3F SEMA3C MXRA5 MYLK PSG4 ICAM1 SEMA3G PTK7 HMCN1 ROBO1 KDR PALLD MUSK ALPK2 | 5.33e-05 | 491 | 153 | 14 | PS50835 |
| Domain | CUB | 5.44e-05 | 50 | 153 | 5 | SM00042 | |
| Domain | - | 6.58e-05 | 52 | 153 | 5 | 2.60.120.290 | |
| Domain | Sushi | 6.58e-05 | 52 | 153 | 5 | PF00084 | |
| Domain | DVL-1 | 6.67e-05 | 2 | 153 | 2 | IPR008340 | |
| Domain | Ig-like_dom | SEMA3F SEMA3C MXRA5 MYLK PSG4 ICAM1 SEMA3G PTK7 HMCN1 ROBO1 KDR PALLD MUSK ALPK2 | 6.90e-05 | 503 | 153 | 14 | IPR007110 |
| Domain | CUB | 7.22e-05 | 53 | 153 | 5 | PS01180 | |
| Domain | - | SEMA3F SEMA3C WDR25 SEMA3G BIRC6 TBL3 CFAP52 RPTOR BOP1 WDR73 WDR77 | 9.64e-05 | 333 | 153 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | SEMA3F SEMA3C WDR25 SEMA3G BIRC6 TBL3 CFAP52 RPTOR BOP1 WDR73 WDR77 | 1.02e-04 | 335 | 153 | 11 | IPR015943 |
| Domain | CUB_dom | 1.03e-04 | 57 | 153 | 5 | IPR000859 | |
| Domain | EGF | 1.41e-04 | 235 | 153 | 9 | SM00181 | |
| Domain | Dishevelled_C-dom | 1.99e-04 | 3 | 153 | 2 | IPR024580 | |
| Domain | Dsh_C | 1.99e-04 | 3 | 153 | 2 | PF12316 | |
| Domain | EGF-like_dom | 2.17e-04 | 249 | 153 | 9 | IPR000742 | |
| Domain | EGF_1 | 2.59e-04 | 255 | 153 | 9 | PS00022 | |
| Domain | EGF-like_CS | 3.07e-04 | 261 | 153 | 9 | IPR013032 | |
| Domain | EGF_2 | 3.43e-04 | 265 | 153 | 9 | PS01186 | |
| Domain | - | SEMA3F SEMA3C POGLUT3 MXRA5 MYLK PSG4 ICAM1 SEMA3G PTK7 HMCN1 ROBO1 KDR PALLD MUSK ALPK2 | 3.66e-04 | 663 | 153 | 15 | 2.60.40.10 |
| Domain | ARM-like | 3.93e-04 | 270 | 153 | 9 | IPR011989 | |
| Domain | GPCR_chapero_1 | 3.96e-04 | 4 | 153 | 2 | PF11904 | |
| Domain | Dsh/Dvl-rel | 3.96e-04 | 4 | 153 | 2 | IPR015506 | |
| Domain | ANKRD13 | 3.96e-04 | 4 | 153 | 2 | IPR021832 | |
| Domain | ARM-type_fold | SMG1 CAND1 RNPEPL1 CKAP5 TRIP12 RPTOR AP3B2 TNPO3 HEATR3 KPNA3 | 4.93e-04 | 339 | 153 | 10 | IPR016024 |
| Domain | - | 4.97e-04 | 222 | 153 | 8 | 1.25.10.10 | |
| Domain | Semaphorin | 5.55e-04 | 20 | 153 | 3 | IPR027231 | |
| Domain | HEAT | 6.37e-04 | 48 | 153 | 4 | PF02985 | |
| Domain | Znf_FCS | 6.56e-04 | 5 | 153 | 2 | IPR012313 | |
| Domain | Ig-like_fold | SEMA3F SEMA3C POGLUT3 MXRA5 MYLK PSG4 ICAM1 SEMA3G PTK7 HMCN1 ROBO1 KDR PALLD MUSK ALPK2 | 7.02e-04 | 706 | 153 | 15 | IPR013783 |
| Domain | EGF_CA | 7.06e-04 | 86 | 153 | 5 | PF07645 | |
| Domain | EGF_3 | 7.22e-04 | 235 | 153 | 8 | PS50026 | |
| Domain | DEP | 7.40e-04 | 22 | 153 | 3 | PF00610 | |
| Domain | DEP | 7.40e-04 | 22 | 153 | 3 | PS50186 | |
| Domain | DEP | 7.40e-04 | 22 | 153 | 3 | SM00049 | |
| Domain | DEP_dom | 8.46e-04 | 23 | 153 | 3 | IPR000591 | |
| Domain | ZF_FCS | 9.79e-04 | 6 | 153 | 2 | PS51024 | |
| Domain | EGF_Ca-bd_CS | 1.22e-03 | 97 | 153 | 5 | IPR018097 | |
| Domain | cEGF | 1.22e-03 | 26 | 153 | 3 | PF12662 | |
| Domain | cEGF | 1.22e-03 | 26 | 153 | 3 | IPR026823 | |
| Domain | HEAT | 1.30e-03 | 58 | 153 | 4 | IPR000357 | |
| Domain | EGF_CA | 1.33e-03 | 99 | 153 | 5 | PS01187 | |
| Domain | 4HBT | 1.36e-03 | 7 | 153 | 2 | PF03061 | |
| Domain | Thioestr_dom | 1.36e-03 | 7 | 153 | 2 | IPR006683 | |
| Domain | ASX_HYDROXYL | 1.39e-03 | 100 | 153 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.80e-03 | 106 | 153 | 5 | IPR000152 | |
| Domain | Semap_dom | 2.05e-03 | 31 | 153 | 3 | IPR001627 | |
| Domain | SEMA | 2.05e-03 | 31 | 153 | 3 | PS51004 | |
| Domain | Sema | 2.05e-03 | 31 | 153 | 3 | SM00630 | |
| Domain | Sema | 2.05e-03 | 31 | 153 | 3 | PF01403 | |
| Domain | Peptidase_S8_His-AS | 2.31e-03 | 9 | 153 | 2 | IPR022398 | |
| Domain | MBT | 2.31e-03 | 9 | 153 | 2 | SM00561 | |
| Domain | MBT | 2.31e-03 | 9 | 153 | 2 | PS51079 | |
| Domain | Peptidase_S8_Ser-AS | 2.31e-03 | 9 | 153 | 2 | IPR023828 | |
| Domain | HEAT_REPEAT | 2.61e-03 | 70 | 153 | 4 | PS50077 | |
| Domain | MBT | 2.87e-03 | 10 | 153 | 2 | PF02820 | |
| Domain | Mbt | 2.87e-03 | 10 | 153 | 2 | IPR004092 | |
| Domain | - | 2.87e-03 | 10 | 153 | 2 | 3.10.129.10 | |
| Domain | Peptidase_S8_subtilisin-rel | 2.87e-03 | 10 | 153 | 2 | IPR015500 | |
| Domain | HotDog_dom | 2.87e-03 | 10 | 153 | 2 | IPR029069 | |
| Domain | SUBTILASE_ASP | 2.87e-03 | 10 | 153 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 2.87e-03 | 10 | 153 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 2.87e-03 | 10 | 153 | 2 | PS00138 | |
| Domain | WD40_repeat_dom | 3.16e-03 | 297 | 153 | 8 | IPR017986 | |
| Domain | EGF_CA | 3.32e-03 | 122 | 153 | 5 | SM00179 | |
| Domain | - | 3.49e-03 | 11 | 153 | 2 | 3.40.50.200 | |
| Domain | GFP-like | 3.49e-03 | 11 | 153 | 2 | IPR023413 | |
| Domain | Ephrin_rec_like | 3.49e-03 | 11 | 153 | 2 | PF07699 | |
| Domain | R3H | 3.49e-03 | 11 | 153 | 2 | PS51061 | |
| Domain | Peptidase_S8/S53_dom | 3.49e-03 | 11 | 153 | 2 | IPR000209 | |
| Domain | - | 3.49e-03 | 11 | 153 | 2 | 2.40.155.10 | |
| Domain | R3H | 3.49e-03 | 11 | 153 | 2 | PF01424 | |
| Domain | - | 3.49e-03 | 11 | 153 | 2 | 3.30.1370.50 | |
| Domain | Peptidase_S8 | 3.49e-03 | 11 | 153 | 2 | PF00082 | |
| Domain | R3H_dom | 3.49e-03 | 11 | 153 | 2 | IPR001374 | |
| Domain | EGF-like_Ca-bd_dom | 3.56e-03 | 124 | 153 | 5 | IPR001881 | |
| Domain | EGF | 3.81e-03 | 126 | 153 | 5 | PF00008 | |
| Domain | EGF_dom | 4.17e-03 | 12 | 153 | 2 | IPR024731 | |
| Domain | EGF_3 | 4.17e-03 | 12 | 153 | 2 | PF12947 | |
| Domain | ASP_PROTEASE | 4.17e-03 | 12 | 153 | 2 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 4.90e-03 | 13 | 153 | 2 | IPR001969 | |
| Domain | WD40 | 5.55e-03 | 259 | 153 | 7 | PF00400 | |
| Domain | PSI | 5.58e-03 | 44 | 153 | 3 | IPR016201 | |
| Domain | Tyr_kinase_cat_dom | 5.93e-03 | 88 | 153 | 4 | IPR020635 | |
| Pubmed | TPP2 SEMA3C POGLUT3 CAND1 ACP2 THUMPD3 STK11IP TRIP12 BIRC6 MBD3 TBL3 IVNS1ABP JAK1 PIGT TJP1 ROBO1 PARN CHID1 CTSB HERC4 PALLD TNPO3 KPNA3 | 2.84e-08 | 1297 | 159 | 23 | 33545068 | |
| Pubmed | 7.15e-08 | 117 | 159 | 8 | 17145500 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 8817329 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 3.74e-07 | 4 | 159 | 3 | 9192851 | |
| Pubmed | Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. | 5.16e-06 | 8 | 159 | 3 | 15454084 | |
| Pubmed | Regulation of AChR clustering by Dishevelled interacting with MuSK and PAK1. | 5.16e-06 | 8 | 159 | 3 | 12165471 | |
| Pubmed | 5.16e-06 | 8 | 159 | 3 | 20006658 | ||
| Pubmed | SMG1 SEMA3C TTC28 ARHGEF5 SLCO4A1 GON4L PTK7 EIF2D YY1AP1 PARN PALLD GARRE1 HEATR3 | 1.00e-05 | 650 | 159 | 13 | 38777146 | |
| Pubmed | 1.10e-05 | 10 | 159 | 3 | 15143170 | ||
| Pubmed | Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels. | 1.20e-05 | 31 | 159 | 4 | 22076636 | |
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 1.20e-05 | 31 | 159 | 4 | 11431694 | |
| Pubmed | Class 3 semaphorins negatively regulate dermal lymphatic network formation. | 1.51e-05 | 11 | 159 | 3 | 26319580 | |
| Pubmed | 2.00e-05 | 12 | 159 | 3 | 19812329 | ||
| Pubmed | 2.00e-05 | 12 | 159 | 3 | 23991118 | ||
| Pubmed | Microtubules enable the planar cell polarity of airway cilia. | 2.00e-05 | 12 | 159 | 3 | 23122850 | |
| Pubmed | Soluble adhesion molecules in Finnish schoolchildren with signs of preclinical type 1 diabetes. | 2.08e-05 | 2 | 159 | 2 | 14737745 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 29609868 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 20404178 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 35205233 | ||
| Pubmed | Newly identified Gon4l/Udu-interacting proteins implicate novel functions. | 2.08e-05 | 2 | 159 | 2 | 32848183 | |
| Pubmed | Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis. | 2.08e-05 | 2 | 159 | 2 | 27834687 | |
| Pubmed | The transcriptional regulator GON4L is required for viability and hematopoiesis in mice. | 2.08e-05 | 2 | 159 | 2 | 33864850 | |
| Pubmed | Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis. | 2.08e-05 | 2 | 159 | 2 | 12414509 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 19419934 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11884469 | ||
| Pubmed | Low zone tolerance requires ICAM-1 expression to limit contact hypersensitivity elicitation. | 2.08e-05 | 2 | 159 | 2 | 19536145 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 10438959 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8644734 | ||
| Pubmed | Biphasic effect of PTK7 on KDR activity in endothelial cells and angiogenesis. | 2.08e-05 | 2 | 159 | 2 | 25986862 | |
| Pubmed | A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. | 2.08e-05 | 2 | 159 | 2 | 9628897 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 16412045 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 12682269 | ||
| Pubmed | Reduced Sympathetic Innervation in Endometriosis is Associated to Semaphorin 3C and 3F Expression. | 2.08e-05 | 2 | 159 | 2 | 27558236 | |
| Pubmed | The Justy mutation identifies Gon4-like as a gene that is essential for B lymphopoiesis. | 2.08e-05 | 2 | 159 | 2 | 20530203 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 16270299 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 34673372 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 21173732 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8856345 | ||
| Pubmed | Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. | 2.08e-05 | 2 | 159 | 2 | 10880393 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 9636189 | ||
| Pubmed | The differential role of L-selectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity. | 2.08e-05 | 2 | 159 | 2 | 20182448 | |
| Pubmed | Intercellular adhesion molecule 1 and selectin l play crucial roles in ulcerative colitis. | 2.08e-05 | 2 | 159 | 2 | 38065859 | |
| Pubmed | Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer. | 2.08e-05 | 2 | 159 | 2 | 24563517 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 26658762 | ||
| Pubmed | Dishevelled2 activates WGEF via its interaction with a unique internal peptide motif of the GEF. | 2.08e-05 | 2 | 159 | 2 | 38714795 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 18028430 | ||
| Pubmed | A crucial role of L-selectin in C protein-induced experimental polymyositis in mice. | 2.08e-05 | 2 | 159 | 2 | 24644046 | |
| Pubmed | Selenoprotein P inhibits cell proliferation and ROX production in HCC cells. | 2.08e-05 | 2 | 159 | 2 | 32735635 | |
| Pubmed | The adhesion molecules of L-selectin and ICAM-1 in thrombocytosis and thrombocytopenia. | 2.08e-05 | 2 | 159 | 2 | 19954409 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 16461740 | ||
| Pubmed | Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1. | 2.08e-05 | 2 | 159 | 2 | 17595378 | |
| Pubmed | TTC28 L3MBTL2 DVL1 DVL2 CKAP5 BIRC6 RLF ZMIZ2 ATF7IP2 CAMSAP1 | 2.46e-05 | 418 | 159 | 10 | 34709266 | |
| Pubmed | CAND1 PSAP ERG TTC28 ADAM23 TTLL5 CKAP5 SYNPO TRIP12 PLEKHH1 JAK1 TJP1 ROBO1 YY1AP1 BACE2 CTSB ZNF292 KPNA3 | 2.59e-05 | 1285 | 159 | 18 | 35914814 | |
| Pubmed | Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons. | 2.59e-05 | 13 | 159 | 3 | 23534961 | |
| Pubmed | 3.05e-05 | 263 | 159 | 8 | 34702444 | ||
| Pubmed | SMG1 POLM TBL3 GPR179 CALHM4 JAK1 FZD8 ZMIZ2 ZFYVE26 WDR73 YY1AP1 BACE2 ZNF679 RAB3IL1 | 3.09e-05 | 832 | 159 | 14 | 36724073 | |
| Pubmed | 3.29e-05 | 14 | 159 | 3 | 25145929 | ||
| Pubmed | Erythro-myeloid progenitors contribute endothelial cells to blood vessels. | 3.29e-05 | 14 | 159 | 3 | 30258231 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TTC28 KLHDC2 ARHGEF5 CKAP5 TRIP12 IVNS1ABP TJP1 STARD9 RPTOR CAMSAP1 PALLD GARRE1 TNPO3 MUSK | 4.48e-05 | 861 | 159 | 14 | 36931259 |
| Pubmed | Identification of APBB1 as a substrate for anaplastic lymphoma kinase. | 4.95e-05 | 44 | 159 | 4 | 39115278 | |
| Pubmed | 5.03e-05 | 16 | 159 | 3 | 22771245 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA3F ARHGEF19 RNPEPL1 DVL1 SLCO4A1 LRRK1 STK11IP BIRC6 MBD3 RPTOR ZMIZ2 NFX1 PIGW ZFYVE26 CAMSAP1 TNPO3 | 5.06e-05 | 1105 | 159 | 16 | 35748872 |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 27529678 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 28381640 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 15852005 | ||
| Pubmed | Differential mediation of the Wnt canonical pathway by mammalian Dishevelleds-1, -2, and -3. | 6.21e-05 | 3 | 159 | 2 | 18093802 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 32900645 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 27744318 | ||
| Pubmed | Binding of APC and dishevelled mediates Wnt5a-regulated focal adhesion dynamics in migrating cells. | 6.21e-05 | 3 | 159 | 2 | 20224554 | |
| Pubmed | The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency. | 6.21e-05 | 3 | 159 | 2 | 32755579 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 32274611 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 22949512 | ||
| Pubmed | Human promoter mutations unveil Oct-1 and GATA-1 opposite action on Gfi1b regulation. | 6.21e-05 | 3 | 159 | 2 | 20143233 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 24039907 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 16116426 | ||
| Pubmed | ICAM-1-dependent pathways regulate colonic eosinophilic inflammation. | 6.21e-05 | 3 | 159 | 2 | 16731772 | |
| Pubmed | Chromosomal localization of the zinc finger protein 15, Zfp15, on mouse chromosome 4. | 6.21e-05 | 3 | 159 | 2 | 7613041 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 32979864 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 12370391 | ||
| Pubmed | The DIX domain targets dishevelled to actin stress fibres and vesicular membranes. | 6.21e-05 | 3 | 159 | 2 | 12384700 | |
| Pubmed | Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia. | 6.21e-05 | 3 | 159 | 2 | 27086035 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 24103557 | ||
| Pubmed | Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway. | 6.21e-05 | 3 | 159 | 2 | 10409711 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 21092292 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 18162551 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 17579093 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 23608756 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 8973355 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 18692936 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 28696394 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 16916660 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 22715394 | ||
| Pubmed | ERG is required for the differentiation of embryonic stem cells along the endothelial lineage. | 6.21e-05 | 3 | 159 | 2 | 20030844 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 25896473 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 11742073 | ||
| Pubmed | Dishevelled proteins are associated with olfactory sensory neuron presynaptic terminals. | 6.21e-05 | 3 | 159 | 2 | 23437169 | |
| Pubmed | Daple coordinates organ-wide and cell-intrinsic polarity to pattern inner-ear hair bundles. | 7.27e-05 | 18 | 159 | 3 | 29229865 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 9.67e-05 | 398 | 159 | 9 | 35016035 | |
| Pubmed | VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. | 1.01e-04 | 20 | 159 | 3 | 21658587 | |
| Pubmed | 1.15e-04 | 407 | 159 | 9 | 12693553 | ||
| Interaction | SCUBE2 interactions | 1.77e-06 | 4 | 155 | 3 | int:SCUBE2 | |
| Cytoband | 1p32.3-p31.3 | 1.19e-05 | 2 | 159 | 2 | 1p32.3-p31.3 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.74e-08 | 161 | 109 | 10 | 593 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.18e-06 | 57 | 109 | 6 | 1179 | |
| GeneFamily | Immunoglobulin like domain containing | 1.69e-04 | 193 | 109 | 7 | 594 | |
| GeneFamily | Dishevelled segment polarity proteins|PDZ domain containing | 2.14e-04 | 4 | 109 | 2 | 505 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.25e-04 | 20 | 109 | 3 | 736 | |
| GeneFamily | WD repeat domain containing | 1.05e-03 | 262 | 109 | 7 | 362 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 1.26e-03 | 9 | 109 | 2 | 1263 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.79e-03 | 40 | 109 | 3 | 321 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 1.92e-03 | 41 | 109 | 3 | 102 | |
| GeneFamily | StAR related lipid transfer domain containing | 3.59e-03 | 15 | 109 | 2 | 759 | |
| GeneFamily | Armadillo repeat containing|Importins | 5.17e-03 | 18 | 109 | 2 | 596 | |
| GeneFamily | Proteases, serine | 6.51e-03 | 63 | 109 | 3 | 738 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 7.02e-03 | 21 | 109 | 2 | 680 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SEMA3C CAND1 TTC28 AHCTF1 CKAP5 EXT1 SOCS6 PRR3 TRIP12 RLF RSBN1 RFTN1 MAP4K5 PARN HERC4 GARRE1 ZNF292 KPNA3 | 3.69e-06 | 856 | 156 | 18 | M4500 |
| Coexpression | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN | FAHD2B MXRA5 ACP2 MBD3 MINDY3 ANKRD33 SLC22A1 C7 RAB3IL1 TNPO3 | 6.07e-06 | 274 | 156 | 10 | M13014 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | TPP2 AHCTF1 GON4L IVNS1ABP JAK1 RSBN1 RHOH ZNF26 ATF7IP2 ZNF292 KPNA3 | 1.20e-05 | 363 | 156 | 11 | M41103 |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN | 2.66e-05 | 199 | 156 | 8 | M3731 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-08 | 181 | 158 | 9 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.02e-08 | 192 | 158 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.16e-08 | 193 | 158 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-08 | 194 | 158 | 9 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-08 | 194 | 158 | 9 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.30e-08 | 194 | 158 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.45e-08 | 195 | 158 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.45e-08 | 195 | 158 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-08 | 196 | 158 | 9 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-08 | 196 | 158 | 9 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.76e-08 | 197 | 158 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.93e-08 | 198 | 158 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.60e-07 | 179 | 158 | 8 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.20e-07 | 184 | 158 | 8 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.62e-07 | 187 | 158 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.77e-07 | 188 | 158 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.77e-07 | 188 | 158 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.77e-07 | 188 | 158 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-07 | 129 | 158 | 7 | 6abdba987c8528f7cb90b32dc01796e02c7352c9 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.09e-07 | 190 | 158 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.26e-07 | 191 | 158 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.43e-07 | 192 | 158 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | EC-Sinusoidal_ECs|EC / Lineage and Cell class | 4.61e-07 | 193 | 158 | 8 | 1291b1d3494dcb4b9309f8bff63fb662e7eca0c8 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.61e-07 | 193 | 158 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.79e-07 | 194 | 158 | 8 | 7f24023df47935286f185dd428d48797daf26f49 | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 4.98e-07 | 195 | 158 | 8 | e8ab3122f81cb22920becd6611cbd9f00db19d50 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.98e-07 | 195 | 158 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.18e-07 | 196 | 158 | 8 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.18e-07 | 196 | 158 | 8 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.18e-07 | 196 | 158 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.18e-07 | 196 | 158 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-07 | 197 | 158 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-07 | 197 | 158 | 8 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.38e-07 | 197 | 158 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.38e-07 | 197 | 158 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-07 | 198 | 158 | 8 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.59e-07 | 198 | 158 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.81e-07 | 199 | 158 | 8 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.81e-07 | 199 | 158 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.81e-07 | 199 | 158 | 8 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.81e-07 | 199 | 158 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.03e-07 | 200 | 158 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.03e-07 | 200 | 158 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-07 | 200 | 158 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-07 | 200 | 158 | 8 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.03e-07 | 200 | 158 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.02e-06 | 164 | 158 | 7 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.28e-06 | 167 | 158 | 7 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.81e-06 | 187 | 158 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.16e-06 | 189 | 158 | 7 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.34e-06 | 190 | 158 | 7 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | Endothelial-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.34e-06 | 190 | 158 | 7 | 6e83fa0eb8cabe0ffb35375f16e6bf3755ec4977 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.34e-06 | 190 | 158 | 7 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | 18-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 5.53e-06 | 191 | 158 | 7 | 86ce98d2c90c196474b06869de888cf5d1eed196 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.53e-06 | 191 | 158 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-06 | 192 | 158 | 7 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 5.72e-06 | 192 | 158 | 7 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.92e-06 | 193 | 158 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 193 | 158 | 7 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.92e-06 | 193 | 158 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | PND14-Endothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 194 | 158 | 7 | cee89d4340738f09d07a159cd6aeee4300776988 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 194 | 158 | 7 | 32962060d80f3edffbe9f0ecad3000c3a9817865 | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.12e-06 | 194 | 158 | 7 | 4199900d16623eca02d674d5ada7f0989e47955e | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.12e-06 | 194 | 158 | 7 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.12e-06 | 194 | 158 | 7 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 194 | 158 | 7 | 44c7d4b75f3b7c9301eba20610e548a01a84ae40 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.12e-06 | 194 | 158 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | facs-Lung-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.12e-06 | 194 | 158 | 7 | 3b5ba12375102598468cb09e66af9241b66c3cf9 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 194 | 158 | 7 | c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.33e-06 | 195 | 158 | 7 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 195 | 158 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 195 | 158 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.33e-06 | 195 | 158 | 7 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-06 | 195 | 158 | 7 | cd011433b3b9bfb1adb13eca2f3f2a5db024cd94 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 196 | 158 | 7 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.55e-06 | 196 | 158 | 7 | bd2c2de103e28b65ea537c22f71225cb0deef1e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 196 | 158 | 7 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.55e-06 | 196 | 158 | 7 | 072a4150ae521c6589b0f7cd60e975fb33715bf4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-06 | 197 | 158 | 7 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-06 | 197 | 158 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-06 | 197 | 158 | 7 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 6.77e-06 | 197 | 158 | 7 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-06 | 197 | 158 | 7 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-06 | 197 | 158 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-06 | 197 | 158 | 7 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 6.77e-06 | 197 | 158 | 7 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-06 | 197 | 158 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-06 | 197 | 158 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 6.99e-06 | 198 | 158 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.99e-06 | 198 | 158 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.99e-06 | 198 | 158 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.99e-06 | 198 | 158 | 7 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.99e-06 | 198 | 158 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.23e-06 | 199 | 158 | 7 | 6e3a226ebba023e3e909d7a7188137da4f1fd7fc | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.23e-06 | 199 | 158 | 7 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.23e-06 | 199 | 158 | 7 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.23e-06 | 199 | 158 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.23e-06 | 199 | 158 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.23e-06 | 199 | 158 | 7 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 7.23e-06 | 199 | 158 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| Disease | salivary gland cancer (implicated_via_orthology) | 2.53e-05 | 2 | 149 | 2 | DOID:8850 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 5.73e-05 | 261 | 149 | 8 | C0004352 | |
| Disease | triacylglycerol 56:6 measurement | 6.61e-05 | 43 | 149 | 4 | EFO_0010433 | |
| Disease | serum gamma-glutamyl transferase measurement | ARHGEF19 GALNT3 ICAM1 GON4L UBE2L3 TJP1 MAP4K5 ZMIZ2 SLC22A1 ROBO1 YY1AP1 RAB3IL1 ALPK2 ZNF292 | 2.31e-04 | 914 | 149 | 14 | EFO_0004532 |
| Disease | level of Phosphatidylethanolamine (16:0_18:2) in blood serum | 2.36e-04 | 24 | 149 | 3 | OBA_2045136 | |
| Disease | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | 2.51e-04 | 5 | 149 | 2 | EFO_0008081 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 2.51e-04 | 5 | 149 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | lysophosphatidylethanolamine 18:2 measurement | 3.01e-04 | 26 | 149 | 3 | EFO_0010369 | |
| Disease | Prostatic Neoplasms | SELENOP ERG GALNT3 ARHGEF5 ICAM1 IVNS1ABP JAK1 JMJD6 ROBO1 CTSB ZNF292 | 3.09e-04 | 616 | 149 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | SELENOP ERG GALNT3 ARHGEF5 ICAM1 IVNS1ABP JAK1 JMJD6 ROBO1 CTSB ZNF292 | 3.09e-04 | 616 | 149 | 11 | C0376358 |
| Disease | docosapentaenoic acid measurement | 3.38e-04 | 27 | 149 | 3 | EFO_0006809 | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 3.75e-04 | 6 | 149 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | intercellular adhesion molecule 4 measurement | 3.75e-04 | 6 | 149 | 2 | EFO_0801708 | |
| Disease | triacylglycerol 56:7 measurement | 4.19e-04 | 29 | 149 | 3 | EFO_0010434 | |
| Disease | L-Selectin measurement | 5.11e-04 | 31 | 149 | 3 | EFO_0008202 | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 5.23e-04 | 7 | 149 | 2 | C0399367 | |
| Disease | level of Phosphatidylcholine (18:2_20:3) in blood serum | 5.23e-04 | 7 | 149 | 2 | OBA_2045108 | |
| Disease | phosphatidylcholine 35:5 measurement | 5.23e-04 | 7 | 149 | 2 | EFO_0021472 | |
| Disease | opioid-binding protein/cell adhesion molecule measurement | 6.95e-04 | 8 | 149 | 2 | EFO_0020618 | |
| Disease | pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) measurement | 6.95e-04 | 8 | 149 | 2 | EFO_0800494 | |
| Disease | 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) measurement | 6.95e-04 | 8 | 149 | 2 | EFO_0800455 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 6.95e-04 | 8 | 149 | 2 | EFO_0801768 | |
| Disease | bipolar I disorder | 7.65e-04 | 141 | 149 | 5 | EFO_0009963 | |
| Disease | Mental deterioration | 8.91e-04 | 9 | 149 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 8.91e-04 | 9 | 149 | 2 | C1270972 | |
| Disease | phosphatidylcholine 39:5 measurement | 8.91e-04 | 9 | 149 | 2 | EFO_0021476 | |
| Disease | level of Phosphatidylcholine (O-18:1_18:2) in blood serum | 8.91e-04 | 9 | 149 | 2 | OBA_2045129 | |
| Disease | level of Phosphatidylcholine (18:0_20:5) in blood serum | 8.91e-04 | 9 | 149 | 2 | OBA_2045095 | |
| Disease | triglyceride measurement, C-reactive protein measurement | 9.35e-04 | 38 | 149 | 3 | EFO_0004458, EFO_0004530 | |
| Disease | lysophosphatidylcholine 20:3 measurement | 1.09e-03 | 40 | 149 | 3 | EFO_0010362 | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 1.11e-03 | 10 | 149 | 2 | EFO_0800608 | |
| Disease | gamma-glutamylthreonine measurement | 1.11e-03 | 10 | 149 | 2 | EFO_0021143 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] measurement | 1.11e-03 | 10 | 149 | 2 | EFO_0800507 | |
| Disease | cholesteryl ester 22:4 measurement | 1.11e-03 | 10 | 149 | 2 | EFO_0021443 | |
| Disease | rheumatoid arthritis, systemic lupus erythematosus | 1.11e-03 | 10 | 149 | 2 | EFO_0000685, MONDO_0007915 | |
| Disease | platelet crit | CACNA1C POGLUT3 ERG TTC28 RNPEPL1 CUBN JAK1 GFI1B MAP4K5 PDE5A TNPO3 KCNQ1DN HEATR3 | 1.12e-03 | 952 | 149 | 13 | EFO_0007985 |
| Disease | lipid measurement, lipoprotein measurement | 1.14e-03 | 90 | 149 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | lysophosphatidylethanolamine measurement | 1.17e-03 | 41 | 149 | 3 | EFO_0010225 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.34e-03 | 160 | 149 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 1.35e-03 | 11 | 149 | 2 | EFO_0800269 | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 1.35e-03 | 11 | 149 | 2 | OBA_2045197 | |
| Disease | lysophosphatidylcholine 20:2 measurement | 1.35e-03 | 11 | 149 | 2 | EFO_0021458 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 1.62e-03 | 12 | 149 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | hyperhomocysteinemia (biomarker_via_orthology) | 1.62e-03 | 12 | 149 | 2 | DOID:9279 (biomarker_via_orthology) | |
| Disease | phosphatidylcholine 34:4 measurement | 1.62e-03 | 12 | 149 | 2 | EFO_0010378 | |
| Disease | triacylglycerol 53:2 measurement | 1.62e-03 | 12 | 149 | 2 | EFO_0021484 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 1.62e-03 | 12 | 149 | 2 | EFO_0800453 | |
| Disease | level of Phosphatidylcholine (16:0_20:2) in blood serum | 1.62e-03 | 12 | 149 | 2 | OBA_2045074 | |
| Disease | triacylglycerol 54:4 measurement | 1.63e-03 | 46 | 149 | 3 | EFO_0010422 | |
| Disease | phosphatidylethanolamine measurement | 1.90e-03 | 173 | 149 | 5 | EFO_0010228 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.90e-03 | 13 | 149 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 1.90e-03 | 13 | 149 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | phosphatidylcholine 40:7 measurement | 1.90e-03 | 13 | 149 | 2 | EFO_0021477 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:4) in blood serum | 1.90e-03 | 13 | 149 | 2 | OBA_2045116 | |
| Disease | pre-eclampsia (implicated_via_orthology) | 1.90e-03 | 13 | 149 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 1.90e-03 | 13 | 149 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 1.90e-03 | 13 | 149 | 2 | OBA_2045082 | |
| Disease | cholesteryl ester 20:3 measurement | 1.96e-03 | 49 | 149 | 3 | EFO_0010347 | |
| Disease | body mass index, fasting blood glucose measurement | 2.20e-03 | 51 | 149 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | Impaired cognition | 2.21e-03 | 14 | 149 | 2 | C0338656 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 2.21e-03 | 14 | 149 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 2.21e-03 | 14 | 149 | 2 | OBA_2045142 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 2.21e-03 | 14 | 149 | 2 | OBA_2045143 | |
| Disease | diacylglycerol 38:4 measurement | 2.21e-03 | 14 | 149 | 2 | EFO_0020066 | |
| Disease | Dupuytren Contracture | 2.23e-03 | 108 | 149 | 4 | EFO_0004229 | |
| Disease | episodic memory | 2.33e-03 | 52 | 149 | 3 | EFO_0004333 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 2.55e-03 | 15 | 149 | 2 | EFO_0800508 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 2.55e-03 | 15 | 149 | 2 | OBA_2045165 | |
| Disease | bipolar disorder | 2.73e-03 | 577 | 149 | 9 | MONDO_0004985 | |
| Disease | Malaria, susceptibility to | 2.90e-03 | 16 | 149 | 2 | cv:C1970028 | |
| Disease | endometriosis (biomarker_via_orthology) | 2.90e-03 | 16 | 149 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | phosphatidylcholine 32:2 measurement | 2.90e-03 | 16 | 149 | 2 | EFO_0010374 | |
| Disease | – | 2.90e-03 | 16 | 149 | 2 | 611162 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 2.90e-03 | 16 | 149 | 2 | OBA_2045090 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 2.90e-03 | 16 | 149 | 2 | OBA_2045093 | |
| Disease | Uremia | 3.28e-03 | 17 | 149 | 2 | C0041948 | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 3.28e-03 | 17 | 149 | 2 | OBA_2045063 | |
| Disease | phosphatidylcholine measurement | 3.29e-03 | 284 | 149 | 6 | EFO_0010226 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 3.32e-03 | 197 | 149 | 5 | EFO_0005680 | |
| Disease | multiple myeloma (is_implicated_in) | 3.34e-03 | 59 | 149 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | respiratory syncytial virus infectious disease (is_marker_for) | 3.67e-03 | 18 | 149 | 2 | DOID:1273 (is_marker_for) | |
| Disease | lysophosphatidylcholine measurement | 3.84e-03 | 62 | 149 | 3 | EFO_0010224 | |
| Disease | lysophosphatidylcholine 20:5 measurement | 4.09e-03 | 19 | 149 | 2 | EFO_0010364 | |
| Disease | diacylglycerol 38:5 measurement | 4.09e-03 | 19 | 149 | 2 | EFO_0020067 | |
| Disease | diacylglycerol 38:3 measurement | 4.09e-03 | 19 | 149 | 2 | EFO_0020065 | |
| Disease | age at menopause | 4.43e-03 | 302 | 149 | 6 | EFO_0004704 | |
| Disease | polyunsaturated fatty acid measurement | 4.46e-03 | 131 | 149 | 4 | EFO_0010733 | |
| Disease | Malaria | 4.53e-03 | 20 | 149 | 2 | C0024530 | |
| Disease | coagulation factor V measurement | 4.53e-03 | 20 | 149 | 2 | EFO_0008087 | |
| Disease | total lipids in very large HDL measurement | 4.58e-03 | 66 | 149 | 3 | EFO_0022312 | |
| Disease | magnesium measurement | 4.58e-03 | 66 | 149 | 3 | EFO_0004845 | |
| Disease | phospholipids in very large HDL measurement | 4.58e-03 | 66 | 149 | 3 | EFO_0022298 | |
| Disease | free cholesterol in large VLDL measurement | 4.98e-03 | 68 | 149 | 3 | EFO_0022265 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 4.99e-03 | 21 | 149 | 2 | OBA_2045083 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNPPSSNWEVEKLSC | 151 | Q9H6S1 | |
| VVKSVAWNPSPAVCL | 456 | Q14137 | |
| NCVPAQSLSEPILWI | 456 | Q9Y5Z0 | |
| SKLTEVPRVCAKPWA | 186 | Q96FF9 | |
| PWDSLLTRCLEKLQP | 456 | P41214 | |
| KPNTPLESRISKQWC | 146 | Q8N336 | |
| NLGIQWEPSSRKPKC | 436 | O75077 | |
| WNSVFPKPGTLVQCL | 706 | Q9NR09 | |
| AREQWPQCPTIKEIR | 86 | P07858 | |
| LRCIISGQPKPEVTW | 31 | Q86TB3 | |
| AKTRPACQDWTVPLP | 876 | Q12774 | |
| DPKLITWSPVCRNDV | 146 | P07203 | |
| WLSQPPARVTIKMEC | 56 | P11308 | |
| EVLPGWTSCVIKDNP | 466 | Q8WXK1 | |
| WVPLLSRILPSDACK | 236 | Q8N6S4 | |
| VSCKQTEVPLSVPWD | 366 | Q8WXI4 | |
| ESCPAPLTTWRQKRE | 846 | Q5T5Y3 | |
| LQSCLPKEWLTPAAL | 141 | Q9BSY9 | |
| PIVLTVAKCWDPSPQ | 346 | O14641 | |
| PSVRNVEVPEWTKCS | 651 | Q13367 | |
| TRPCPSWKAVRVDLV | 406 | Q9NP87 | |
| LAAVPVPWKSTDPCQ | 16 | Q8TBN0 | |
| SKCLQWLQPRDSTSP | 381 | Q7Z3H0 | |
| GWQLTCVLPTPVVKT | 401 | Q14699 | |
| IPWIAPECVEDSKNL | 756 | P23458 | |
| WKEADSKRLNPQCIP | 531 | O95453 | |
| EKQRWISALCPSSPQ | 691 | Q8IW93 | |
| EFTSWVPLVSKICPS | 136 | Q86YJ7 | |
| TDDTPIKRCLQTKWP | 416 | Q9H8M7 | |
| LPLWRERPQKTASNC | 751 | P56730 | |
| TWVIVNLCRNKDPPP | 221 | O00505 | |
| WCLFPTSTPRELIKV | 206 | Q6NYC1 | |
| SCKITGRPQPQVTWL | 181 | Q15746 | |
| SVKVWQDACSPLPKT | 2966 | Q16787 | |
| WTTPSLKCIRDPALV | 86 | Q13261 | |
| PNTDCSLPTKVFWIA | 181 | Q05BQ5 | |
| EKNPGVWLNTTQPLC | 201 | O95983 | |
| DPVTKLWTSCAPLNI | 486 | Q9Y6Y0 | |
| TPAKTEICPWEVNER | 1586 | Q6PRD1 | |
| AETCPWEVTERIPVK | 2016 | Q6PRD1 | |
| GWCAINSKILVPPRT | 271 | Q969R5 | |
| AALPPQEKWTCRQLK | 486 | Q38SD2 | |
| PNQCLDWTNLKREPE | 51 | Q5VTD9 | |
| EKCPTLNGQPQWSAL | 46 | Q9H478 | |
| KLQTPKEEVSWPCPQ | 1591 | Q6ZU64 | |
| LLKQTRPVQSWLCDP | 401 | Q86VP6 | |
| ELDLPNRKIWPTECQ | 186 | Q8N1V2 | |
| SVPPTDKVCLWLGAN | 116 | P61758 | |
| DTARTWLPTQPQRKC | 441 | Q6UW60 | |
| TACDLSAITKPWPIQ | 761 | O76074 | |
| RCPNPTKQIWTVNEA | 391 | Q5GLZ8 | |
| LNTWELSEGTNCPPK | 91 | Q9NQ92 | |
| QCVESSPLVPIQQEW | 101 | Q6ZR08 | |
| VKNPEWSRNEIPHSC | 426 | Q12986 | |
| PIKLPCNSENVTWLK | 1241 | Q5T7B8 | |
| CNSENVTWLKPRPIS | 1246 | Q5T7B8 | |
| SGIWSNPSPICQKLD | 306 | P14151 | |
| VPLKCLAQEVNIPDW | 136 | Q9Y4W2 | |
| KWICDNIEITPTPAQ | 286 | A1L453 | |
| RLQTIWKEEPIPCTA | 211 | P16083 | |
| CEVKGDPTPTIQWNR | 4371 | Q96RW7 | |
| CKVSGLPTPDLSWQL | 1156 | Q8WX93 | |
| RLTEPVVPKDWQQEC | 356 | P11117 | |
| CPSPTDRAQWLEKTQ | 491 | Q3KR16 | |
| CTWVIDSPPHQQVKI | 3306 | O60494 | |
| QFWPLVEIQCSPDLK | 71 | Q9H461 | |
| PPTCIQLLDSSNWKE | 601 | Q14008 | |
| IAVDLCSRNPTWKPL | 441 | Q7Z4Q2 | |
| NPIRRACISIVEWKP | 111 | Q13936 | |
| AQIIVLWNCDKPLPA | 511 | Q16394 | |
| QALNKWEPELPSCSR | 281 | P17927 | |
| QALNKWEPELPSCSR | 731 | P17927 | |
| QALNKWEPELPSCSR | 1181 | P17927 | |
| PWNAPESIQKAAKCI | 466 | Q49AN0 | |
| VQNWLVEVPTVSPIC | 176 | Q69384 | |
| VTFLAPVTWPDKVVC | 96 | Q6P2I3 | |
| PVVHCDINVPSKWQT | 116 | A8MYV0 | |
| VSCNPSDPLQKWILS | 616 | Q14435 | |
| IVVQVPSTWCLKEDP | 446 | O15063 | |
| KENPLTQAVPKCQRW | 691 | P10643 | |
| EFPCLPKQVAWILAT | 786 | Q3T8J9 | |
| DKLPSQPKEVQTLWC | 351 | Q9NSG2 | |
| IPSCQDWKDISVPTL | 266 | Q5JW98 | |
| SPANSCPQIQKLWSI | 271 | A6NJJ6 | |
| SICISIPPLFWRQAK | 166 | P28221 | |
| AQLPPGEKLTCWQAV | 756 | Q8IY82 | |
| WNITKINPKCAPVES | 596 | Q5U623 | |
| QWERIDCQGIPPSSK | 131 | Q9Y2U9 | |
| ISLTVAKCWDPTPRS | 331 | O14640 | |
| LPSWQPVGKNLTLRC | 121 | P05362 | |
| TTPKKCAVPVETEWL | 1256 | Q8WYP5 | |
| VCEWRPPEQLKQLLD | 71 | Q6ZQY3 | |
| SCPKSRKLAPENWSV | 81 | Q8NDH2 | |
| QLNPSENCTWTIERP | 51 | Q86UP6 | |
| ISLTVAKCWDPTPRS | 331 | P54792 | |
| PPVKSVSRWCIDSEL | 186 | Q9Y238 | |
| APPCTQRITWKGVLL | 6 | Q00888 | |
| ANTECTWTINPPPKR | 831 | Q9NQ36 | |
| CVPESPRWLLSQKRN | 281 | O15245 | |
| PVPSNKTTCENWREI | 26 | Q8NE79 | |
| PNAPLSWVRACVQVL | 271 | Q9BWS9 | |
| PLKINCATSWIHPDT | 506 | Q9Y4K4 | |
| RILLWDTRCPKPASQ | 191 | Q9BQA1 | |
| PPVSQCVQWVDEAKL | 641 | Q5VWQ0 | |
| DVLQSLPPAWRNCVS | 906 | Q8N1F8 | |
| RVWAEPCLLPTATSK | 276 | Q9HAU8 | |
| PITLKRPICKDNWQA | 31 | Q5MJ70 | |
| SPVSLELTPKDQCWV | 181 | A6NIE9 | |
| CQPRSPQATVKWLFQ | 626 | Q13275 | |
| ECAPKSPQASIKWLL | 591 | Q99985 | |
| EVVPEWASCLKSPRI | 691 | Q8N3V7 | |
| NKWIGEIRSNLPCTP | 96 | Q15669 | |
| WSLIKNTCPPKDDPQ | 136 | P79522 | |
| TPPNLLAKELWSSCT | 2291 | Q96Q15 | |
| CVDPWLTQTRKTCPI | 256 | Q9H6Y7 | |
| RNTPSEPIHCIVWAK | 176 | Q9UBT2 | |
| PGQAVDCIWTIKATP | 201 | Q8NC67 | |
| WTSQPPLCKVTQTTD | 821 | Q6UXD5 | |
| RLKHTCSPQEDSPWQ | 3196 | Q9P2P6 | |
| TPLSPVEIECAKWLQ | 51 | Q9BVR0 | |
| RENIPEWKNCIIVSP | 156 | P21108 | |
| DWCRSPPPVQVSEKV | 651 | Q4LDE5 | |
| SLCKQPPAWSIRDQD | 26 | P49908 | |
| VKTTPCARLECWIDP | 76 | Q8N122 | |
| LVPCSWKLIQSPVTN | 406 | Q7Z7B1 | |
| PLDTSKQPLCQLWAE | 51 | Q96BD0 | |
| PKQKFERPICVSWST | 541 | Q14246 | |
| DPQAWQKTLSCPTKE | 146 | Q7Z4H8 | |
| ICKSSILQWPDNPKA | 996 | Q9NR97 | |
| QWPTELLLFTKTEPC | 456 | A4D1E1 | |
| LPREVVCTENLTPWK | 176 | Q969N2 | |
| PCEVWLPFLQSLQES | 146 | Q13129 | |
| CLPVISAENWKPATK | 86 | A0A1B0GUS4 | |
| VILKDCSVPNPSWNK | 41 | Q5T1C6 | |
| CSVPNPSWNKDLRLL | 46 | Q5T1C6 | |
| SQDCTVKLWPLPKAL | 441 | Q12788 | |
| PPCVNKVSDWKLEIL | 76 | Q9UNG2 | |
| PSPQAIWSITCKGDI | 726 | Q7Z6L1 | |
| KPDLITCLEQNKEPW | 61 | Q8IYX0 | |
| WKNPVLCTILSQEPL | 161 | O60281 | |
| PCITLKNWVQTLRPV | 786 | P29144 | |
| CVATGSPVPTILWRK | 476 | Q9Y6N7 | |
| TVWNKPTVKSLPCDI | 51 | P07602 | |
| LTTKWATLQGCSPPE | 1196 | Q9ULM0 | |
| EITIDPTCSWKPVPV | 671 | Q8NF64 | |
| LPIDAVQWDICNLPL | 381 | Q9BV44 | |
| THPCQKVIQEIWPVL | 631 | Q9Y5L0 | |
| ANEFPCLPKQVAWIL | 261 | Q9H869 | |
| VELRLPHCDPKTWQN | 1711 | Q07157 | |
| SRCSQKKWPEVLLSP | 296 | Q969Z4 | |
| QCVLVSLWPVPVAAS | 1651 | Q96AY4 | |
| PAVPWKDLTCLRASQ | 146 | Q8NF99 | |
| DPWIINAKISRQSCP | 71 | P17031 | |
| LECLPKSPQAAVRWL | 601 | Q9NS98 | |
| GELPTPVCKNLDTLW | 596 | P35968 | |
| RGPVNTIQWCPVLSK | 246 | Q64LD2 | |
| TWPLPLSTDQCIKSN | 466 | Q1EHB4 | |
| NIPTWLTELGKTCPF | 1526 | Q14669 | |
| LDCLTQATPKPTVVW | 431 | Q13308 | |
| LEWCIQQSSNPIPKR | 416 | Q68DK2 | |
| PWPLRPTNSEETCIK | 136 | O14544 | |
| PELLRVTWAPGLKNC | 276 | Q6P4I2 | |
| KPWLLEVNLSPSLAC | 361 | Q6EMB2 | |
| CLPVISAENWKPATK | 86 | P68036 | |
| GSPDWAQVPCLQKRT | 151 | Q8TCI5 | |
| ECLAKGTPAPQISWI | 1971 | Q9NR99 | |
| WNELKVVSPVCRPAA | 356 | O15146 |